ACROLINE Trademark

Trademark Overview

On Tuesday, December 15, 2020, a trademark application was filed for ACROLINE with the United States Patent and Trademark Office. The USPTO has given the ACROLINE trademark a serial number of 90382863. The federal status of this trademark filing is REGISTERED as of Tuesday, February 14, 2023. This trademark is owned by Pfizer Inc.. The ACROLINE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information in the field of growth hormone disorders, treatments, and therapies
acroline

General Information

Serial Number90382863
Word MarkACROLINE
Filing DateTuesday, December 15, 2020
Status700 - REGISTERED
Status DateTuesday, February 14, 2023
Registration Number6981110
Registration DateTuesday, February 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements

Goods and ServicesProviding medical information in the field of growth hormone disorders, treatments, and therapies

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 23, 2021
Primary Code044
First Use Anywhere DateSaturday, April 30, 2022
First Use In Commerce DateSaturday, April 30, 2022

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 14, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 10, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, January 8, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Thursday, December 15, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 30, 2022USE AMENDMENT FILED
Thursday, December 15, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 30, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, June 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 27, 2022SOU EXTENSION 2 GRANTED
Monday, June 27, 2022SOU EXTENSION 2 FILED
Monday, June 27, 2022TEAS EXTENSION RECEIVED
Thursday, December 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 14, 2021SOU EXTENSION 1 GRANTED
Tuesday, December 14, 2021SOU EXTENSION 1 FILED
Tuesday, December 14, 2021TEAS EXTENSION RECEIVED
Tuesday, July 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 21, 2021ASSIGNED TO EXAMINER
Tuesday, February 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 18, 2020NEW APPLICATION ENTERED

Related Keywords

acroline disorders treatments therapies hormone growth medical information field providing